Contraceptive Market Size, Share & Trends Report, 2028

Contraceptive Market: Industry Perspective

The global contraceptive market size was worth around USD 22.1 billion in 2021 and is predicted to grow to around USD 41.3 billion by 2028 with a compound annual growth rate (CAGR) of roughly 8.25% between 2022 and 2028.

The report analyzes the global contraceptive market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the contraceptive industry.

Request Free Sample

Contraceptive Market: Overview

Unmet needs for contraception in both emerging economies and industrially developed countries have steered demand for contraceptive methods in upcoming years. Furthermore, contraceptive use assists in reducing sexually transmitted diseases and unwanted pregnancies. Cost-effectivity of contraceptives and the rise in funding of research activities related to producing new kinds of contraceptives with additional features are predicted to generate new growth avenues for the contraceptive industry in the ensuing years.

Reportedly, contraceptive use among married women enhanced across the globe from nearly 31% between 1960 and 1965 to about 58% in 1990. However, the surge was more rapid in emerging economies where the use of contraceptives in married women increased from 10% in 1960-1963 to about 54% in 1990. For the record, the rise was drastic in East Asia & Latin America and a little lesser in some other parts of Asia and North Africa.

Contraceptive Market: Growth Dynamics

Expansion of the contraceptive market over the forecast timeline is subject to the growing need for reducing the risk of sexually transmitted disorders and health-related problems. In addition to this, an increase in several gynecologists preferring contraception devices for birth control will soar the progression of the contraceptive market. An increase in awareness about new kinds of contraceptives along with a surge in utilization of oral pills will result in massive demand for contraceptive equipment. Furthermore, technological breakthroughs & acceptance of new contraception tools will play a pivotal part in the growth of the contraceptive industry. Nonetheless, the hazardous effects of contraceptive medicines can pose a challenge to the growth of the contraceptive market. Additionally, injectable contraceptive administration has resulted in abdominal bleeding, depression, and alopecia. Apart from this, the rise in cases of infertility caused due to intake of contraceptive pills can also hamper the business landscape.

Furthermore, oral contraceptives protect individuals against fallopian tube infection, ovarian cysts, and anemia risk. Moreover, it helps in reducing menstrual pain as well as pain occurring during ovulation. Male contraceptives such as condoms offer protection against viral and bacterial infection and delay sperm allergy & premature ejaculation along with helping in increasing penile erection. Contraceptives such as spermicides offer protection against gonorrhea and chlamydia as well as against sexually transmitted diseases such as syphilis. All these aforementioned aspects will boost growth in the contraceptive market size.

The world's female population is experiencing continuous growth and presently female population in the world is around 3.5 Billion. Maternal mortality is increasing day by day and approximately 800 women die every day as a result of poor, unplanned and unhealthy pregnancy and childbirth. As compared to older women, young pregnant women face a higher risk of complications and death as a result of pregnancy. As a result, the contraception market is rapidly growing with increasing awareness towards improving maternal health. The contraception market is driven by the rising use of contraception drugs & devices and the introduction of new contraception products.

In addition, contraception product has a strong hold on the market due to the increasing prevalence of sexually transmitted diseases. According to the World Health Organization, more than 500 million people are suffering from genital infection with herpes simplex virus (HSV) while more than 290 million women have a human papillomavirus (HPV) infection. However, increasing the prevalence of side effects due to improper use of contraception products and low use of contraception by poor women in developing countries may act as a roadblock to the contraception market. Nonetheless, untapped markets and newly launched contraception products are projected to generate new opportunities in the next five years.

Request Free Sample

Contraceptive Market: Segmentation

The contraceptive market is segmented into product, gender, distribution channel, and region.

Based on the product, the contraceptive market is segmented into oral contraceptive pills, topical contraceptive pills, injectable contraceptive pills, diaphragms, vaginal rings, condoms, contraceptive sponges, subdermal implants, and intra-uterine devices. In developing countries, the use of contraceptive pills is increasing among college students. Thus, the contraceptive pills segment dominated the contraceptive market.  Female sterilization contraception is a permanent contraception procedure to prevent pregnancy. In 2015, the female sterilization segment accounted for more than 25% market share. Thus, in the forecast period, these two segments are expected to exhibit noticeable growth due to rising awareness of personal care.

By gender, The contraceptive market is divided into male and female. The female segment dominates the contraceptive market due to the wide range of available products and strong demand for effective and long-term contraceptive solutions. However, the Male segment is steadily gaining attention, supported by the growing emphasis on shared responsibility, innovations in male contraceptive methods, and the continued popularity of condoms. Both segments play critical roles in addressing global reproductive health needs.

Contraceptive Market: Report Scope

Contraceptive Market: Regional Landscape

North America To Contribute Majorly Towards Regional Market Size By 2028

Growth of the regional market over the forecasting timeline is due to growing awareness about birth control pills in countries such as the U.S. Reportedly, the cost-efficiency of contraception in countries such as the U.S. will drive regional market trends. Huge acceptance of new products in North America will embellish the expansion of the contraceptive market in North America.

Rise in the launching of awareness schemes related to the use of contraceptives & high focus on family planning programs by the U.S. government will proliferate the size of the contraceptive market in the sub-continent.

Recent Developments:

• In December 2020, the Irish Government declared a plan to launch free contraception to women ranging from 17 years to 25 years.
• In July 2018, the U.S. administration announced the extension of the exemption facility to exclude the Affordable Care Act law that mandates staff to encompass birth control coverage in a health insurance policy.

Contraceptive Market: Competitive Landscape

The global contraceptive market is dominated by players like:

• The Female Health Company
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Amgen Inc.
• Bayer Healthcare Pharmaceuticals LLC
• Pfizer, Inc.
• Piramal Healthcare Limited
• Reckitt Benckiser Group PLC
• Lupin Pharmaceuticals, Inc.
• Cipla Limited
• Novartis AG
• Glenmark Pharmaceuticals Limited.

The global Contraceptive Market is segmented as follows:

By Product

• Oral Contraceptive Pills
• Topical Contraceptive Pills
• Injectable Contraceptive Pills
• Diaphragms
• Vaginal Rings
• Condoms
• Contraceptive Sponges,
• Subdermal Implants
• Intra-Uterine Devices

By Gender

• Male
• Female

By Distribution Channel

• Hospitals & Clinics
• Retail Pharmacies
• Online Channels
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa